Dr. Erin Tree
@drtinytree.bsky.social
Pediatric rheumatologist, mother, foodie, reader, traveler, sports fan, chocoholic | #MedSky #RheumSky #PedsRheumSky
I’m looking forward to seeing the pediatric data
October 27, 2025 at 5:58 PM
I’m looking forward to seeing the pediatric data
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: sJIA treatment
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
October 27, 2025 at 3:53 PM
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: sJIA treatment
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
October 27, 2025 at 3:31 PM
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
3. UCAN Biologic Classification: lots of patients and large amount of data yielded 5 clusters with clinical and biologic characteristics and distinct patterns of joint involvement
#ACR25 #ACRambassador
3. UCAN Biologic Classification: lots of patients and large amount of data yielded 5 clusters with clinical and biologic characteristics and distinct patterns of joint involvement
#ACR25 #ACRambassador
October 27, 2025 at 3:31 PM
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
3. UCAN Biologic Classification: lots of patients and large amount of data yielded 5 clusters with clinical and biologic characteristics and distinct patterns of joint involvement
#ACR25 #ACRambassador
3. UCAN Biologic Classification: lots of patients and large amount of data yielded 5 clusters with clinical and biologic characteristics and distinct patterns of joint involvement
#ACR25 #ACRambassador
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
2. Clinical exam doesn’t tell the whole story. Concern= patients with subclinical disease but high cytokine levels.
#ACR25 #ACRambassador
2. Clinical exam doesn’t tell the whole story. Concern= patients with subclinical disease but high cytokine levels.
#ACR25 #ACRambassador
October 27, 2025 at 3:31 PM
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
2. Clinical exam doesn’t tell the whole story. Concern= patients with subclinical disease but high cytokine levels.
#ACR25 #ACRambassador
2. Clinical exam doesn’t tell the whole story. Concern= patients with subclinical disease but high cytokine levels.
#ACR25 #ACRambassador
She is amazing! Glad you were able to make her talk!
October 27, 2025 at 1:05 AM
She is amazing! Glad you were able to make her talk!
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Social Media
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Social Media
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Understanding Disease
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Understanding Disease
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Guidelines
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Guidelines
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Medications
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Medications
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
#ACR25 Clinical Year in Review by Dr. Bryant England (2/2): #Lupus
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
October 26, 2025 at 1:58 PM
#ACR25 Clinical Year in Review by Dr. Bryant England (2/2): #Lupus
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador